Last-line antibiotics are failing: options to address this urgent threat to patients and healthcare systems

The emergence and spread of highly-resistant bacteria, especially those resistant to ‘last-line’ antibiotics, such as carbapenems and colistin, is a grave public health concern and a threat to patient safety and economies in Europe and globally.